Search

everythinglearnresearchcommunity

for

Search:↓

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

PDF2 senses specific lipids and regulates root growth and gene expression in Arabidopsis.

The Itpr3 gene causes a specific hair pattern in mice.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

RALF22 is essential for root hair growth in response to fungal emissions in Arabidopsis.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

WRKY transcription factors help plants manage stress and support growth.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

An allele of the KRTAP13-2 gene may improve wool quality in sheep.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

A new genetic variant causes BRESHECK syndrome by disrupting cell growth and stress response.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Raptor and Rictor have stable expression in hair cycles, with Raptor marking stem cells and Rictor involved in hair shaft formation.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

RXR and RAR proteins in skin may help with cell growth, hair growth, and gland function.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Low TRPS1 expression in skin and hair cells is linked to hair problems in Trichorhinophalangeal syndrome.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

TRF1 is crucial for creating and maintaining stem cells and marks both pluripotent and adult stem cells.